{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:53:55Z","timestamp":1794048835385,"version":"4.8.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010628","name":"Universidad de La Sabana","doi-asserted-by":"publisher","award":["MED-289-2020"],"award-info":[{"award-number":["MED-289-2020"]}],"id":[{"id":"10.13039\/501100010628","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010628","name":"Universidad de La Sabana","doi-asserted-by":"publisher","award":["MED-289-2020"],"award-info":[{"award-number":["MED-289-2020"]}],"id":[{"id":"10.13039\/501100010628","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Patients with community-acquired pneumonia (CAP) admitted to the intensive care unit (ICU) have high mortality rates during the acute infection and up to ten years thereafter. Recommendations from international CAP guidelines include macrolide-based treatment. However, there is no data on the long-term outcomes of this recommendation. Therefore, we aimed to determine the impact of macrolide-based therapy on long-term mortality in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Registered patients in the MIMIC-IV database 16\u00a0years or older and admitted to the ICU due to CAP were included. Multivariate analysis, targeted maximum likelihood estimation (TMLE) to simulate a randomised controlled trial, and survival analyses were conducted to test the effect of macrolide-based treatment on mortality six-month (6\u00a0m) and twelve-month (12\u00a0m) after hospital admission. A sensitivity analysis was performed excluding patients with\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      or MRSA pneumonia to control for Healthcare-Associated Pneumonia (HCAP).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      3775 patients were included, and 1154 were treated with a macrolide-based treatment. The non-macrolide-based group had worse long-term clinical outcomes, represented by 6\u00a0m [31.5 (363\/1154) vs 39.5 (1035\/2621),\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001] and 12\u00a0m mortality [39.0 (450\/1154) vs 45.7 (1198\/2621),\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001]. The main risk factors associated with long-term mortality were Charlson comorbidity index, SAPS II, septic shock, and respiratory failure. Macrolide-based treatment reduced the risk of dying at 6\u00a0m [HR (95% CI) 0.69 (0.60, 0.78),\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001] and 12\u00a0m [0.72 (0.64, 0.81),\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001]. After TMLE, the protective effect continued with an additive effect estimate of \u2212\u20090.069.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Macrolide-based treatment reduced the hazard risk of long-term mortality by almost one-third. This effect remains after simulating an RCT with TMLE and the sensitivity analysis for the HCAP classification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-023-04466-x","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T01:02:07Z","timestamp":1685494927000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Impact of macrolide treatment on long-term mortality in patients admitted to the ICU due to CAP: a targeted maximum likelihood estimation and survival analysis"],"prefix":"10.1186","volume":"27","author":[{"given":"Luis Felipe","family":"Reyes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa D.","family":"Ib\u00e1\u00f1ez-Prada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian C.","family":"Serrano-Mayorga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuli V.","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alirio","family":"Bastidas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e9lica","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Frei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo Anthony","family":"Celi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Martin-Loeches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Waterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,31]]},"reference":[{"issue":"12","key":"4466_CR1","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/S1473-3099(16)30267-5","volume":"16","author":"S Aliberti","year":"2016","unstructured":"Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators G. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016;16(12):1364\u201376.","journal-title":"Lancet Infect Dis"},{"issue":"21","key":"4466_CR2","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1001\/jama.2009.1754","volume":"302","author":"JL Vincent","year":"2009","unstructured":"Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K, Investigators EIGo. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323\u20139.","journal-title":"JAMA"},{"issue":"5","key":"4466_CR3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa1500245","volume":"373","author":"S Jain","year":"2015","unstructured":"Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, Reed C, Grijalva CG, Anderson EJ, Courtney DM, Chappell JD, Qi C, Hart EM, Carroll F, Trabue C, Donnelly HK, Williams DJ, Zhu Y, Arnold SR, Ampofo K, Waterer GW, Levine M, Lindstrom S, Winchell JM, Katz JM, Erdman D, Schneider E, Hicks LA, McCullers JA, Pavia AT, Edwards KM, Finelli L, Team CES. Community-acquired pneumonia requiring hospitalisation among U.S. adults. N Engl J Med. 2015;373(5):415\u201327.","journal-title":"N Engl J Med"},{"key":"4466_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1471-2334-13-94","volume":"13","author":"A Khawaja","year":"2013","unstructured":"Khawaja A, Zubairi AB, Durrani FK, Zafar A. Etiology and outcome of severe community acquired pneumonia in immunocompetent adults. BMC Infect Dis. 2013;13:94.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"4466_CR5","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1086\/651669","volume":"31","author":"MI Restrepo","year":"2010","unstructured":"Restrepo MI, Anzueto A, Arroliga AC, Afessa B, Atkinson MJ, Ho NJ, Schinner R, Bracken RL, Kollef MH. Economic burden of ventilator-associated pneumonia based on total resource utilisation. Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am. 2010;31(5):509\u201315.","journal-title":"Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am"},{"issue":"10053","key":"4466_CR6","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","volume":"388","author":"GBD Mortality","year":"2016","unstructured":"Mortality GBD, Causes of Death C. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459\u2013544.","journal-title":"Lancet"},{"issue":"4","key":"4466_CR7","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1055\/s-0040-1713003","volume":"41","author":"RG Wunderink","year":"2020","unstructured":"Wunderink RG, Feldman C. Community-acquired pneumonia: a global perspective. Semin Respir Crit Care Med. 2020;41(4):453\u20134.","journal-title":"Semin Respir Crit Care Med"},{"issue":"3","key":"4466_CR8","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1183\/20734735.0205-2019","volume":"15","author":"D Severiche-Bueno","year":"2019","unstructured":"Severiche-Bueno D, Parra-Tanoux D, Reyes LF, Waterer GW. Hot topics and current controversies in community-acquired pneumonia. Breathe (Sheff). 2019;15(3):216\u201325.","journal-title":"Breathe (Sheff)"},{"issue":"6","key":"4466_CR9","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1055\/s-0036-1593754","volume":"37","author":"MI Restrepo","year":"2016","unstructured":"Restrepo MI, Reyes LF, Anzueto A. Complication of community-acquired pneumonia (including cardiac complications). Semin Respir Crit Care Med. 2016;37(6):897\u2013904.","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"4466_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1056\/NEJMra1808137","volume":"380","author":"DM Musher","year":"2019","unstructured":"Musher DM, Abers MS, Corrales-Medina VF. Acute infection and myocardial infarction. N Engl J Med. 2019;380(2):171\u20136.","journal-title":"N Engl J Med"},{"issue":"5","key":"4466_CR11","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1164\/rccm.201701-0104OC","volume":"196","author":"LF Reyes","year":"2017","unstructured":"Reyes LF, Restrepo MI, Hinojosa CA, Soni NJ, Anzueto A, Babu BL, Gonzalez-Juarbe N, Rodriguez AH, Jimenez A, Chalmers JD, Aliberti S, Sibila O, Winter VT, Coalson JJ, Giavedoni LD, Dela Cruz CS, Waterer GW, Witzenrath M, Suttorp N, Dube PH, Orihuela CJ. Severe pneumococcal pneumonia causes acute cardiac toxicity and subsequent cardiac remodeling. Am J Respir Crit Care Med. 2017;196(5):609\u201320.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"4466_CR12","doi-asserted-by":"publisher","first-page":"e711","DOI":"10.1093\/cid\/ciaa1427","volume":"72","author":"HF Africano","year":"2021","unstructured":"Africano HF, Serrano-Mayorga CC, Ramirez-Valbuena PC, Bustos IG, Bastidas A, Vargas HA, Gomez S, Rodriguez A, Orihuela CJ, Reyes LF. Major adverse cardiovascular events during invasive pneumococcal disease are serotype dependent. Clin Infect Dis. 2021;72(11):e711\u20139.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"4466_CR13","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, Cooley LA, Dean NC, Fine MJ, Flanders SA, Griffin MR, Metersky ML, Musher DM, Restrepo MI, Whitney CG. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45\u201367.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"4466_CR14","doi-asserted-by":"publisher","first-page":"15290","DOI":"10.1038\/s41598-019-51711-x","volume":"9","author":"A Schmid","year":"2019","unstructured":"Schmid A, Wolfensberger A, Nemeth J, Schreiber PW, Sax H, Kuster SP. Monotherapy versus combination therapy for multidrug-resistant gram-negative infections: systematic review and meta-analysis. Sci Rep. 2019;9(1):15290.","journal-title":"Sci Rep"},{"issue":"4","key":"4466_CR15","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/s00134-009-1730-y","volume":"36","author":"I Martin-Loeches","year":"2010","unstructured":"Martin-Loeches I, Lisboa T, Rodriguez A, Putensen C, Annane D, Garnacho-Montero J, Restrepo MI, Rello J. Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia. Intensiv Care Med. 2010;36(4):612\u201320.","journal-title":"Intensiv Care Med"},{"issue":"21","key":"4466_CR16","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1001\/jama.2014.4304","volume":"311","author":"EM Mortensen","year":"2014","unstructured":"Mortensen EM, Halm EA, Pugh MJ, Copeland LA, Metersky M, Fine MJ, Johnson CS, Alvarez CA, Frei CR, Good C, Restrepo MI, Downs JR, Anzueto A. Association of azithromycin with mortality and cardiovascular events among older patients hospitalised with pneumonia. JAMA. 2014;311(21):2199\u2013208.","journal-title":"JAMA"},{"key":"4466_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13054-016-1414-2","volume":"20","author":"J Phua","year":"2016","unstructured":"Phua J, Dean NC, Guo Q, Kuan WS, Lim HF, Lim TK. Severe community-acquired pneumonia: timely management measures in the first 24 hours. Crit Care. 2016;20:237.","journal-title":"Crit Care"},{"issue":"2","key":"4466_CR18","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1378\/chest.15-0484","volume":"148","author":"C Feldman","year":"2015","unstructured":"Feldman C, Anderson R. Community-acquired pneumonia: pathogenesis of acute cardiac events and potential adjunctive therapies. Chest. 2015;148(2):523\u201332.","journal-title":"Chest"},{"issue":"5","key":"4466_CR19","doi-asserted-by":"publisher","first-page":"871","DOI":"10.17219\/acem\/61953","volume":"25","author":"E Radzikowska","year":"2016","unstructured":"Radzikowska E, Rozy A, Jagus P, Polubiec-Kownacka M, Wiatr E, Chorostowska-Wynimko J, Roszkowski-Sliz K. Clarithromycin decreases IL-6 concentration in serum and BAL fluid in patients with cryptogenic organizing pneumonia. Adv Clin Exp Med. 2016;25(5):871\u20138.","journal-title":"Adv Clin Exp Med"},{"issue":"5","key":"4466_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.resinv.2015.05.003","volume":"53","author":"M Emmet O'Brien","year":"2015","unstructured":"Emmet O\u2019Brien M, Restrepo MI, Martin-Loeches I. Update on the combination effect of macrolide antibiotics in community-acquired pneumonia. Respir Investig. 2015;53(5):201\u20139.","journal-title":"Respir Investig"},{"issue":"12","key":"4466_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005337","volume":"11","author":"N Gonzalez-Juarbe","year":"2015","unstructured":"Gonzalez-Juarbe N, Gilley RP, Hinojosa CA, Bradley KM, Kamei A, Gao G, Dube PH, Bergman MA, Orihuela CJ. Pore-forming toxins induce macrophage necroptosis during acute bacterial pneumonia. PLoS Pathog. 2015;11(12): e1005337.","journal-title":"PLoS Pathog"},{"issue":"4","key":"4466_CR22","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00408-016-9900-5","volume":"194","author":"JG Nel","year":"2016","unstructured":"Nel JG, Durandt C, Mitchell TJ, Feldman C, Anderson R, Tintinger GR. Pneumolysin mediates platelet activation in vitro. Lung. 2016;194(4):589\u201393.","journal-title":"Lung"},{"issue":"1","key":"4466_CR23","doi-asserted-by":"publisher","first-page":"e00569","DOI":"10.1128\/IAI.00569-17","volume":"86","author":"T Brissac","year":"2018","unstructured":"Brissac T, Shenoy AT, Patterson LA, Orihuela CJ. Cell invasion and pyruvate oxidase derived H2O2 are critical for Streptococcus pneumoniae mediated cardiomyocyte killing. Infect Immun. 2018;86(1):e00569-e617.","journal-title":"Infect Immun"},{"issue":"8","key":"4466_CR24","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.3201\/eid2608.201413","volume":"26","author":"C Duployez","year":"2020","unstructured":"Duployez C, Le Guern R, Tinez C, Lejeune AL, Robriquet L, Six S, Loiez C, Wallet F. Panton-valentine leukocidin-secreting Staphylococcus aureus pneumonia complicating COVID-19. Emerg Infect Dis. 2020;26(8):1939\u201341.","journal-title":"Emerg Infect Dis"},{"key":"4466_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2016.35","volume":"3","author":"AE Johnson","year":"2016","unstructured":"Johnson AE, Pollard TJ, Shen L, Lehman LW, Feng M, Ghassemi M, Moody B, Szolovits P, Celi LA, Mark RG. MIMIC-III, a freely accessible critical care database. Sci Data. 2016;3: 160035.","journal-title":"Sci Data"},{"issue":"1","key":"4466_CR26","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1183\/09031936.00145810","volume":"38","author":"J Wood","year":"2011","unstructured":"Wood J, Butler CC, Hood K, Kelly MJ, Verheij T, Little P, Torres A, Blasi F, Schaberg T, Goossens H, Nuttall J, Coenen S. Antibiotic prescribing for adults with acute cough\/lower respiratory tract infection: congruence with guidelines. Eur Respir J. 2011;38(1):112\u20138.","journal-title":"Eur Respir J"},{"issue":"4","key":"4466_CR27","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1007\/s12325-020-01248-7","volume":"37","author":"J Ferreira-Coimbra","year":"2020","unstructured":"Ferreira-Coimbra J, Sarda C, Rello J. Burden of community-acquired pneumonia and unmet clinical needs. Adv Ther. 2020;37(4):1302\u201318.","journal-title":"Adv Ther"},{"issue":"12","key":"4466_CR28","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1086\/379712","volume":"37","author":"EM Mortensen","year":"2003","unstructured":"Mortensen EM, Kapoor WN, Chang CC, Fine MJ. Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia. Clin Infect Dis. 2003;37(12):1617\u201324.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"4466_CR29","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/MD.0b013e318190f444","volume":"87","author":"J Johnstone","year":"2008","unstructured":"Johnstone J, Eurich DT, Majumdar SR, Jin Y, Marrie TJ. Long-term morbidity and mortality after hospitalisation with community-acquired pneumonia: a population-based cohort study. Medicine (Baltimore). 2008;87(6):329\u201334.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"4466_CR30","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.jcrc.2015.03.009","volume":"30","author":"KC Honselmann","year":"2015","unstructured":"Honselmann KC, Buthut F, Heuwer B, Karadag S, Sayk F, Kurowski V, Thiele H, Droemann D, Wolfrum S. Long-term mortality and quality of life in intensive care patients treated for pneumonia and\/or sepsis: predictors of mortality and quality of life in patients with sepsis\/pneumonia. J Crit Care. 2015;30(4):721\u20136.","journal-title":"J Crit Care"},{"issue":"9","key":"4466_CR31","doi-asserted-by":"publisher","first-page":"e442","DOI":"10.1093\/cid\/ciaa1140","volume":"72","author":"LF Reyes","year":"2021","unstructured":"Reyes LF, Garcia-Gallo E, Pinedo J, Saenz-Valcarcel M, Celi L, Rodriguez A, Waterer G. Scores to predict long-term mortality in patients with severe pneumonia still lacking. Clin Infect Dis. 2021;72(9):e442\u20133.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"4466_CR32","doi-asserted-by":"publisher","DOI":"10.36416\/1806-3756\/e20200257","volume":"47","author":"LF Bahlis","year":"2021","unstructured":"Bahlis LF, Diogo LP, Fuchs SC. Charlson comorbidity index and other predictors of in-hospital mortality among adults with community-acquired pneumonia. J Bras Pneumol. 2021;47(1): e20200257.","journal-title":"J Bras Pneumol"},{"issue":"3","key":"4466_CR33","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1159\/000479089","volume":"94","author":"J Almirall","year":"2017","unstructured":"Almirall J, Serra-Prat M, Bolibar I, Balasso V. Risk factors for community-acquired pneumonia in adults: a systematic review of observational studies. Respiration. 2017;94(3):299\u2013311.","journal-title":"Respiration"},{"issue":"2","key":"4466_CR34","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1164\/rccm.201511-2234OC","volume":"194","author":"NI Lone","year":"2016","unstructured":"Lone NI, Gillies MA, Haddow C, Dobbie R, Rowan KM, Wild SH, Murray GD, Walsh TS. Five-year mortality and hospital costs associated with surviving intensive care. Am J Respir Crit Care Med. 2016;194(2):198\u2013208.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"4466_CR35","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/17476348.2020.1743182","volume":"14","author":"MF Mart","year":"2020","unstructured":"Mart MF, Ware LB. The long-lasting effects of the acute respiratory distress syndrome. Expert Rev Respir Med. 2020;14(6):577\u201386.","journal-title":"Expert Rev Respir Med"},{"issue":"3","key":"4466_CR36","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s00134-013-3186-3","volume":"40","author":"CY Wang","year":"2014","unstructured":"Wang CY, Calfee CS, Paul DW, Janz DR, May AK, Zhuo H, Bernard GR, Matthay MA, Ware LB, Kangelaris KN. One-year mortality and predictors of death among hospital survivors of acute respiratory distress syndrome. Intensiv Care Med. 2014;40(3):388\u201396.","journal-title":"Intensiv Care Med"},{"issue":"1","key":"4466_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004283","volume":"4","author":"HE Wang","year":"2014","unstructured":"Wang HE, Szychowski JM, Griffin R, Safford MM, Shapiro NI, Howard G. Long-term mortality after community-acquired sepsis: a longitudinal population-based cohort study. BMJ Open. 2014;4(1): e004283.","journal-title":"BMJ Open"},{"issue":"5","key":"4466_CR38","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/resp.13248","volume":"23","author":"G Waterer","year":"2018","unstructured":"Waterer G. Empiric antibiotics for community-acquired pneumonia: A macrolide and a beta-lactam please! Respirology. 2018;23(5):450\u20131.","journal-title":"Respirology"},{"issue":"5","key":"4466_CR39","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1378\/chest.123.5.1328","volume":"123","author":"GW Waterer","year":"2003","unstructured":"Waterer GW. Combination antibiotic therapy with macrolides in community-acquired pneumonia: More smoke but is there any fire? Chest. 2003;123(5):1328\u20139.","journal-title":"Chest"},{"issue":"2","key":"4466_CR40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/QCO.0000000000000819","volume":"35","author":"I Martin-Loeches","year":"2022","unstructured":"Martin-Loeches I, Garduno A, Povoa P, Nseir S. Choosing antibiotic therapy for severe community-acquired pneumonia. Curr Opin Infect Dis. 2022;35(2):133\u20139.","journal-title":"Curr Opin Infect Dis"},{"issue":"5","key":"4466_CR41","doi-asserted-by":"publisher","first-page":"609","DOI":"10.4187\/respcare.05943","volume":"63","author":"AW Huckle","year":"2018","unstructured":"Huckle AW, Fairclough LC, Todd I. Prophylactic antibiotic use in COPD and the potential anti-inflammatory activities of antibiotics. Respir Care. 2018;63(5):609\u201319.","journal-title":"Respir Care"},{"issue":"14","key":"4466_CR42","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1056\/NEJMoa1406330","volume":"372","author":"DF Postma","year":"2015","unstructured":"Postma DF, van Werkhoven CH, van Elden LJ, Thijsen SF, Hoepelman AI, Kluytmans JA, Boersma WG, Compaijen CJ, van der Wall E, Prins JM, Oosterheert JJ, Bonten MJ, Group C-SS. Antibiotic treatment strategies for community-acquired pneumonia in adults. N Engl J Med. 2015;372(14):1312\u201323.","journal-title":"N Engl J Med"},{"issue":"6","key":"4466_CR43","first-page":"1","volume":"54","author":"R Konig","year":"2015","unstructured":"Konig R, Cao X, Oswald M, Forstner C, Rohde G, Rupp J, Witzenrath M, Welte T, Kolditz M, Pletz M, Group CS. Macrolide combination therapy for patients hospitalised with community-acquired pneumonia? An individualised approach supported by machine learning. Eur Respir J 2019;54(6):1-11.","journal-title":"Eur Respir J"},{"issue":"5","key":"4466_CR44","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/resp.13232","volume":"23","author":"J Okumura","year":"2018","unstructured":"Okumura J, Shindo Y, Takahashi K, Sano M, Sugino Y, Yagi T, Taniguchi H, Saka H, Matsui S, Hasegawa Y, Central Japan Lung Study G. Mortality in patients with community-onset pneumonia at low risk of drug-resistant pathogens: impact of beta-lactam plus macrolide combination therapy. Respirology. 2018;23(5):526\u201334.","journal-title":"Respirology"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04466-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-023-04466-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04466-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T13:05:25Z","timestamp":1685538325000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-023-04466-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,31]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4466"],"URL":"https:\/\/doi.org\/10.1186\/s13054-023-04466-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2615595\/v1","asserted-by":"object"}]},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,31]]},"assertion":[{"value":"22 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not require IRB approval as used open source and ammonized data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"212"}}